Gastric Bypass Stent System Market Global Report 2026

The gastric bypass stent system market size has grown rapidly in recent years. It will grow from $0.41 billion in 2025 to $0.46 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to rising prevalence of obesity and bariatric surgeries, increasing incidence of gastrointestinal complications post surgery, growth in hospital based endoscopic procedures, expansion of minimally invasive surgical techniques, rising awareness of advanced gastrointestinal treatment options.

The gastric bypass stent system market size is expected to see rapid growth in the next few years. It will grow to $0.7 billion in 2030 at a compound annual growth rate (CAGR) of 11%. The growth in the forecast period can be attributed to increasing adoption of precision medicine in gastrointestinal care, rising demand for biodegradable and biocompatible stent materials, growth in robotic assisted endoscopic procedures, expansion of ambulatory surgical centers for faster recovery treatments, integration of AI based diagnostic support in gastrointestinal interventions. Major trends in the forecast period include increasing adoption of minimally invasive gastrointestinal stenting procedures for post bariatric surgery complications, growing preference for self expanding nitinol stents due to flexibility and reduced migration risk, rising use of fully covered stents for improved leak management and tissue healing, expansion of hospital based endoscopic intervention procedures for obesity related complications, increasing demand for advanced biodegradable stent materials to reduce long term device removal risks.

The rising prevalence of obesity is expected to propel the growth of the gastric bypass stent system market going forward. Obesity is a medical condition in which excess body fat accumulates to a level that can harm health, usually indicated by a BMI of 30 or higher. Obesity is increasing mainly due to high consumption of processed, calorie-dense foods combined with reduced physical activity in modern sedentary lifestyles, leading to more energy intake than the body burns. Gastric bypass stent systems help manage obesity by creating a temporary passage in the digestive tract that reduces food absorption and promotes early satiety, enabling patients to lose weight without undergoing permanent invasive bariatric surgery. For instance, in March 2025, according to the World Obesity Federation, a UK-based membership organization, by 2030, nearly 3 billion adults, around 50% of the global adult population, will be affected by overweight or obesity. Therefore, the rising prevalence of obesity is driving the growth of the gastric bypass stent system market.

The increasing adoption of minimally invasive procedures is expected to propel the growth of the gastric bypass stent system market going forward. Minimally invasive procedures are medical treatments performed through small incisions or natural openings using specialized instruments to reduce pain, tissue damage, and recovery time compared to open surgery. The growing adoption of minimally invasive procedures is driven by advancements in medical technology, which are making treatments safer, more precise, and applicable to a broader range of conditions. Gastric bypass stent systems support minimally invasive approaches by offering a non-surgical or endoscopic method for managing obesity and gastrointestinal conditions, reducing the need for open surgery, minimizing tissue damage, shortening recovery time, and lowering the risk of postoperative complications. For instance, in September 2023, according to the National Library of Medicine, a US-based federal government agency, 7,733 robotic surgical systems were installed worldwide, and more than 10 million robotic surgeries have been performed. Therefore, the increasing adoption of minimally invasive procedures is driving the growth of the gastric bypass stent system market.

Major companies operating in the gastric bypass stent system market are focusing on developing advanced minimally invasive obesity treatment solutions to improve weight management outcomes, reduce surgical complications, and enhance patient recovery. Minimally invasive obesity treatment refers to advanced medical procedures that support weight reduction through less invasive techniques, minimizing surgical trauma, recovery time, and complication risks compared to conventional bariatric surgery. For instance, in April 2024, Hangzhou Tongee Medical Technology Co., Ltd., a China-based medical device company, received approval from China’s National Medical Products Administration (NMPA) for its innovative Gastric Bypass Stent System. The system consists of delivery and retrieval components and is designed to isolate the contact between chyme and the intestinal tract, achieving effects similar to gastric bypass surgery without altering the physiological structure of the gastrointestinal tract. The device is intended for obesity patients with ineffective lifestyle modification and poor response to non-invasive or drug treatments, providing a new minimally invasive option for obesity management.

Major companies operating in the gastric bypass stent system market are Hangzhou Tongee Medical Technology Co. Ltd.; Boston Scientific; Cook Medical; Olympus Corporation; Medtronic.

North America was the largest region in the gastric bypass stent system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric bypass stent system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gastric bypass stent system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastric bypass stent system market consists of sales of lumen-apposing stents, anti-migration stent systems, and drug-eluting stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The gastric bypass stent system market research report is one of a series of new reports that provides gastric bypass stent system market statistics, including gastric bypass stent system industry global market size, regional shares, competitors with a gastric bypass stent system market share, detailed gastric bypass stent system market segments, market trends and opportunities, and any further data you may need to thrive in the gastric bypass stent system industry. This gastric bypass stent system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.